發明
中華民國
101117920
I 486341
抑制ATR與FANCD2激活之組成物與方法Methods and compositions for inhibition of ATR and FANCD2 activation
高雄醫學大學
2015/06/01
癌症治療時造成DNA損傷會活化ATM與ATR磷酸酶進而啟動Chk1和Chk2磷酸酶活化,這也就是DNA損傷反應的訊息傳遞。過去研究已經證實ATR抑制劑對於ATM或p53缺陷的癌症細胞能夠促進DNA損傷藥物的療效。本技術係揭示式 (I) 或式 (II) 兩系列黃酮類架構化合物或所形成之藥學組合物,可抑制ATR與FANCD2之DNA複製、細胞週期監測點和DNA修復的功能,而具備改善DNA損傷類之抗癌藥物的敏感性,以及預後不良之症狀。 DNA damage caused during cancer treatment can rapidly activate the ataxia telangiectasia-mutated (ATM)/Rad3-related (ATR)-dependent phosphorylation of Chk2 and Chk1 kinases, which are hallmarks of DNA damage response (DDR). Pharmacological inhibition of ATR causes a synthetic lethal effect on ATM or p53 defective cancers suggest that such inhibition is an effective way of improving the sensitivity of cancers to DNA-damaging agents. This invention is announcing a composition of flavonoid skeleton in the formula (I) or formula (II) compound, which inhibites functions of ATR and FANCD2 on DNA replication, damage checkpoint, and repair; therefore, this composition can improve the cancer sensitivity and poor prognosis to DNA-damaging theraputices.
智財保護與科技管理組
07-3138030
版權所有 © 國家科學及技術委員會 National Science and Technology Council All Rights Reserved.
建議使用IE 11或以上版本瀏覽器,最佳瀏覽解析度為1024x768以上|政府網站資料開放宣告
主辦單位:國家科學及技術委員會 執行單位:台灣經濟研究院 網站維護:台灣經濟研究院